Ovid Therapeutics Inc. Common Stock (NASDAQ: OVID) last traded at $2.19, down 9.13% on the session. The quote above updates while this page is open; the figures below are drawn from Ovid Therapeutics Inc. Common Stock’s own filings and are restated only when a new one is published.
Ovid Therapeutics Inc. Common Stock trades on NASDAQ under the ticker OVID. Its market capitalisation is $427.70 million.
Valuation measures for Ovid Therapeutics Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $427.70M |
|---|---|
| Enterprise value | $438.46M |
| Price / sales | 270.18 |
| Price / book | 2.04 |
| Beta | 1.30 |
Trailing-twelve-month figures tagged in Ovid Therapeutics Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $1.58M |
|---|---|
| Net income (TTM) | -$34.49M |
| Operating margin | -3686.67% |
| Return on equity | -16.43% |
| Cash | $11.33M |
Range and volume for OVID over the past 52 weeks.
| 52-week high | $3.11 |
|---|---|
| 52-week low | $1.18 |
| Volume | 1.64M |
| Average volume | 1.57M |
| Previous close | $2.41 |
Invest a chosen dollar amount in Ovid Therapeutics Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell OVID.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.